Article
Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype.
BMC cancer - 16 Dec 2014
Miura Yuji, Imamura Chiyo K, Fukunaga Koya, Katsuyama Yoshihiko, Suyama Koichi, Okaneya Toshikazu, Mushiroda Taisei, Ando Yuichi, Takano Toshimi, Tanigawara Yusuke
Abstract excerpt
BACKGROUND: Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor that acts against receptors for vascular endothelial growth factor and platelet-derived growth factor. Common toxicities of sunitinib treatment include hypertension, hand-foot syndrome, vomiting, and diarrhea, and the pr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
